SUBSCRIBE
SUBSCRIBE
News   Drug Development

US FDA Orders New Warnings for GlaxoSmithKline, AstraZeneca PLC Drugs

June 3, 2010 | 
1 min read
Reuters -- U.S. health regulators have finalized new warnings for controversial inhaled asthma drugs, but exercised new powers to order the changes on products made by GlaxoSmithKline Plc and AstraZeneca Plc.
Clinical research Postmarket research
AstraZeneca Pharmaceuticals LP GlaxoSmithKline Food and Drug Administration (FDA)
MORE ON THIS TOPIC
3d rendering medical heart in yellow background
Cardiovascular disease
Amgen, Merck, Novo, More Take Cardiovascular Benefits to New Heights at AHA 2025
November 11, 2025
 · 
5 min read
 · 
Tristan Manalac
Unhappy young woman feel lonely abandoned in crowd suffer from communication lack. Upset girl struggle with depression or mental disorder. Psychological problem. Flat vector illustration.
Depression
Neurocrine’s Depression Drug Delivers ‘Surprise’ Phase II Miss
November 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Changing or transforming, turning around, challenging the odds and conquering adversity, a businessman pole vaulting from the down arrow to the up arrow of growth
Cancer
Cogent Hits ‘Unprecedented’ Efficacy in Rare Stomach Cancer, Clearing Path to FDA
November 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Modern collage with human heart and hands stock illustration
Cardiovascular disease
Ionis’ Tryngolza ‘Game-Changing in Lowering Triglycerides, Cementing Case for FDA Filing
November 10, 2025
 · 
2 min read
 · 
Tristan Manalac